MediSafe has raised $6 million Series A round led by Pitango Venture Capital with participation from 7wire ventures, and investors from previous rounds, including lool Ventures, TriVentures and Eyal Gura.
MediSafe’s mobile-first approach involves creating personalized interventions to the major causes of non-adherence – forgetfulness, lack of support, emotional distress, information overload, low engagement, and rising medication costs. Through its platform and mobile apps, the company is enabling tighter care coordination between patients, caregivers or “MedFriends,” physicians, and other providers.
The company will use the new funds to accelerate user growth in the U.S. market, where nearly half of Americans are prescribed at least one medication on a daily basis. MediSafe will focus on expanding the suite of medication management solutions available, enhancing overall user experience within its mHealth apps, and accelerating market penetration through a network of distribution, technology and data partnerships.
MediSafe will focus on expanding the suite of medication management solutions available.As part of the deal, MediSafe has relocated its headquarters to Boston, Massachusetts and hired Jon Michaeli as Executive Vice President of Marketing and Business Development. Mr. Michaeli comes to MediSafe from Sermo, where he worked with physicians and other healthcare industry constituents for over three and a half years.
“We believe adherence is a critical pillar to improve quality of care on a global scale, and in the near term, we are focusing our efforts in the U.S. given the dynamics and the speed of mobile technology adoption in this healthcare market,” said MediSafe’s CEO, Omri ‘Bob’ Shor. “This funding will support our growth in the U.S., as we continue to expand our platform, with the mission of bringing value to patients through connectivity to key stakeholders in the healthcare continuum.”